Errors in Dx and Rx of TB

Similar documents
TB Update: March 2012

Diagnosis and Medical Management of Latent TB Infection

Pediatric Tuberculosis Lisa Y. Armitige, MD, PhD September 14, 2017

PREVENTION OF TUBERCULOSIS. Dr Amitesh Aggarwal

Pediatric TB Lisa Armitige, MD, PhD September 28, 2011

DIAGNOSIS AND MEDICAL MANAGEMENT OF TB DISEASE

TB Intensive Houston, Texas. Childhood Tuberculosis Kim Connelly Smith. November 12, 2009

Tuberculosis Tools: A Clinical Update

Diagnosis and Treatment of Tuberculosis, 2011

TB Classification (ATS/CDC)

TB: Management in an era of multiple drug resistance. Bob Belknap M.D. Denver Public Health November 2012

TB and Comorbidities Adriana Vasquez, MD April 12, 2018

TB Nurse Case Management San Antonio, Texas July 18 20, 2012

Latent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016

TB In Detroit 2011* Early TB: Smudge Sign. Who is at risk for exposure to or infection with TB? Who is at risk for TB after exposure or infection?

TB in the Patient with HIV

has the following disclosures to make:

Fundamentals of Tuberculosis (TB)

TUBERCULOSIS. Pathogenesis and Transmission

TB Nurse Case Management San Antonio, Texas March 7 9, Pediatric TB Kim Connelly Smith, MD, MPH March 8, 2012

Mycobacterial Infections: What the Primary Provider Should Know about Tuberculosis

10/3/2017. Updates in Tuberculosis. Global Tuberculosis, WHO 2015 report. Objectives. Disclosures. I have nothing to disclose

Diagnosis & Medical Case Management of TB Disease. Lisa Armitige, MD, PhD October 22, 2015

Tuberculosis: update 2013

I. Demographic Information GENDER NUMBER OF CASES PERCENT OF CASES. Male % Female %

TUBERCULOSIS. Presented By: Public Health Madison & Dane County

TB the basics. (Dr) Margaret (DHA) and John (INZ)

5. HIV-positive individuals treated with INH should receive Pyridoxine (B6) 25 mg daily or 50 mg twice/thrice weekly on the same schedule as INH

What the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Global Impact of TB

Tuberculosis Intensive

What you need to know about diagnosing and treating TB: a preventable, fatal disease. Bob Belknap M.D. Denver Public Health November 2014

Tuberculosis and Diabetes Mellitus. Lana Kay Tyer, RN MSN WA State Department of Health TB Nurse Consultant

TB in Foreign Born and High Risk Populations

Diagnosis and Medical Management of TB Disease. Quratulian Annie Kizilbash, MD, MPH March 17, 2015

TB Intensive San Antonio, Texas May 7-10, 2013

Pre-Treatment Evaluation. Treatment of Latent TB Infection (LTBI) Initiating Treatment: Patient Education. Before initiating treatment for LTBI:

CLINICAL DIAGNOSIS AND MANAGEMENT OF TB Disease

Tuberculosis, HIV, and Corrections James B. McAuley, MD, MPH April 22, 2009

CHAPTER 3: DEFINITION OF TERMS

Approach to Co-infection with TB and HIV: 2011 Henry Fraimow, MD

TB Intensive San Antonio, Texas. TB/HIV Co-Infection. Lisa Armitige, MD, PhD has the following disclosures to make:

What the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Life Cycle of M. tuberculosis

TB Nurse Case Management San Antonio, Texas April 9-11, 2013

Understanding and Managing Latent TB Infection Arnold, Missouri October 5, 2010

Tuberculosis Intensive

Latent TB Infection (LTBI) Strategies for Detection and Management

Tuberculosis Populations at Risk

Tuberculosis Intensive

Tuberculosis Pathogenesis

Summary Statistics of Reported and Verified Cases of Tuberculosis in San Joaquin County in 2012, (N=44) County Rate = 6.3 Cases per 100,000 Population

Treatment of Tuberculosis

Pediatric TB Intensive Houston, Texas October 14, 2013

Contact Investigation and Prevention in the USA

Treatment of Tuberculosis, 2017

Contact Investigation

Tuberculosis: A Provider s Guide to

Disclosures. TB and CoMorbidities Challenges and Opportunities. Burden of TB. Outline of the lecture. Target testing for TB Infection TB HIV 3/25/2012

The Epidemiology of Tuberculosis in Minnesota,

TB & HIV CO-INFECTION IN CHILDREN. Reené Naidoo Paediatric Infectious Diseases Broadreach Healthcare 19 April 2012

Northwestern Polytechnic University

TB Intensive San Antonio, Texas August 7-10, 2012

Latent Tuberculosis Best Practices

Utilizing All the Tools in the TB Toolbox

Immune Reconstitution Inflammatory Syndrome. Dr. Lesego Mawela

At the end of this session, participants will be able to:

Tuberculosis in Primary Care COC GTA Spring Symposium Dr Elizabeth Rea April 2013

Tuberculosis and Diabetes Dec. 10, 2009 Dean Schillinger, M.D. and Gisela Schecter, M.D., M.P.H. 1 of 18

Case Management of the TB/HIV Infected Patient

Treatment of Tuberculosis Disease. Treatment of Tuberculosis. Decision to Treat Initiation of Therapy 1

Diagnosis and Management of TB Disease Lisa Armitige, MD, PhD September 27, 2011

Pediatric Drug-Resistant TB in China

Chapter 22. Pulmonary Infections

Research in Tuberculosis: Translation into Practice

TB/HIV CO-INFECTION ADULT & CHILDREN (INCLUDING INH PROPHYLAXIS) ART Treatment Guideline Training 31 st January to 4 th February, 2011

8/28/2017. Learning Objectives. After attending this presentation, learners will be able to:

TUBERCULOSIS AND THE TNF-α INHIBITORS. Lloyd Friedman, M.D. Yale University Milford Hospital

TB and Co-Morbidities Lisa Armitige, MD, PhD September 27, 2011

CHAPTER:1 TUBERCULOSIS. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY

TB in the Correctional Setting Florence, Arizona October 7, 2014

Treatment of TB Infection Lisa Y. Armitige, MD, PhD April 7, 2015

2016 Annual Tuberculosis Report For Fresno County

INDEX CASE INFORMATION

TB Intensive San Antonio, Texas December 1-3, 2010

TB Nurse Assessment. Ginny Dowell, RN, BSN October 21, 2015

Tuberculosis Exposure, Infection, and Disease Among Children with Medical Comorbidities

TB, or NOT TB? A Tough Question in Kids!

New Tuberculosis Guidelines. Jason Stout, MD, MHS

Communicable Disease Control Manual Chapter 4: Tuberculosis. Assessment and Follow-Up of TB Contacts

TUBERCULOSIS IN HEALTHCARE SETTINGS Diana M. Nilsen, MD, FCCP Director of Medical Affairs, Bureau of Tuberculosis Control New York City Department of

LTBI Treatment and Anti TNF alpha

The Diagnosis of Active TB. Deborah McMahan, MD TB Intensive September 28, 2017

TUBERCULOSIS CONTACT INVESTIGATION

Pediatric TB Radiology: It s Not Black and White Part 2

Treatment of Tuberculosis

3/25/2012. numerous micro-organismsorganisms

Treatment of Active Tuberculosis

Management of Pediatric Tuberculosis in New Jersey

Tuberculosis What you need to know. James Zoretic M.D., M.P.H. Regions 2 and 3 Director

Treating TB What Happened? All the Patients Have Challenging Co-Morbid Conditions Now!

Transcription:

Errors in Dx and Rx of TB David Schlossberg, MD, FACP Professor of Medicine Temple University School of Medicine Medical Director, TB Control Program Philadelphia Department of Public Health TB Still a threat 1/3of the world infected 2-3 million deaths/year Diagnosis is slow Rx is long and complicated Many pitfalls in Dx and Rx It might be TB; let s do a PPD 1

False-negative PPD Active tuberculosis (~25%) Miliary tuberculosis (~50%) Immunosuppression, e.g. AIDS, Steroids Waning with age (~5% per year) Vaccination, viral illness IGRAs S S Sensitivity ~ PPD. Remember, it is an immunologic test, also Sputum Smear is usually positive 2

SPUTUM STAIN vs. CULTURE False Ө Sputum Smear Smear: 5000-10,000 AFB C+S: 10-100 AFB As many as 50% of cases Negative Sputum Smear Smear-negative TB is not contagious sputum much more contagious - but: 1/6 cases smearnegative contact 3

Percentage of persons infected, by sputum Smear positivity and proximity of index case Negative cultures rule out TB Culture-negative TB Sputum: 17% in US Extra-pulmonary variable: Cerebrospinal fluid: 30-50% Urine: 20% Peritoneal fluid: 75% Consider PCR urine, fixed tissue Culture-negative TB 17%! Alternative Dx Stop TB Rx Prove TB - Rx Empiric TB Rx No improvement by 2 mos - stop Rx TB cultures negative Improvement Rx for 4 months 4

A Normal CXR rules out TB TB in Advanced AIDS Frequently atypical: CXR: clear; lower-lung zone infiltrates; adenopathy Extrapulmonary involvement up to 70%: lymphatic, meningeal, pleural, hepatic, renal, splenic, spinal, cutaneous, miliary dissemination PPD negative in majority May have no symptoms (5% of one cohort of HIV pts) African post mortem studies: TB was cause of death in ~ 40%, but was suspected in only 50% pre-mortem 5

TB Pleural effusions persist if untreated Beware the self-limited Pleural effusion! Body Cavities: Tissue > Fluid Negative pleural fluid culture rules out TB Tuberculosis of: Pleura Pericardium Synovium Peritoneum 6

Miliary TB CXR may be negative initially If in doubt, repeat it. Sputum smear/culture SHOULD be negative --unless pulm TB present also 7

The Ten Commandments How TB is treated with one drug 1. Treating LTBI with stable CXR 2. Adding one drug to a failing regimen 3. Starting Rx with only 2 drugs before sensitivity known Number XI: Do not treat TB with one drug Inactive?? The CXR can determine if disease is active 8

LTBI = R/O active TB: Beware the Misleading X-ray Reports: Stable inactive healed fibrotic old scarring If regimen is failing, add one new drug Can not tell activity from CXR. If in doubt, wait for C&S or begin Rx with 4 drugs Treatment Isoniazid Rifampin Ethambutol Never Add Just One! March June October Smear + + + Culture + + + That s why we begin Rx with at least 4 drugs: INH Rifampin PZA (shortens Rx to 6 months) Ethambutol (in case of INH Resistance) Susceptibility Isoniazid R R R Rifampin S R R Ethambutol S S R 9

Starting with just 2 drugs PZA does not protect against resistance. Therefore, assume INH resistance and don t start, e.g. with INH plus rifampin INH Resistance Japan 3% new 19% prior Rx USA 8% new 14% prior Rx Korea 12% China 13% Philippines 14% Russia 16% Vietnam 19% Infectiousness Isolation can be discontinued once Rx is begun Isolation in hospital Clinical response 3 consecutive AFB-negative smears Two weeks of Rx (5-7 days if smear negative) Can leave hospital while still contagious Home Isolation 10

Home Isolation Can discharge patients while still contagious Clinical judgment: what is home situation, regarding susceptibles, e.g. children, immunosuppressed, etc. Isolate at home: no visitors, ventilation, cough into tissues, mask for doctor visits, etc. Isolate until criteria satisfied, i.e. 3 negative smears and 2 weeks of Rx with clinical response Worsening on Rx = Rx Failure IRIS Known TB may appear to worsen on Rx OR Unsuspected TB may be unmasked Both HIV-positive and HIV-negative patients Seen with TNF-alpha antagonists Described post-partum lymphocyte reactivity normalizes in 24 hours IRIS Epidemiology Normal patients during anti-tb Rx HIV infection ART Transplantation immunosuppressive Rx Pregnancy post-partum Neutropenia rapid recovery after colonystimulating growth factor After Rx with TNF-alpha antagonists 11

Subcutaneous abscess Immune Reconstitution in patient with AIDS And Miliary TB, on HAART Vidal J, et. al. Rev. Inst. Med. Trop. S. Paulo vol.45 no.3 São Paulo May/June 2003 http://www.itg.be/itg/distancelearning/lecturenotesvandenendene/imagehtml/ppages/cd_1082_013c.htm IRIS Risk: Timing of Rx Timing of ART in TB Balancing IRIS/pill burden/drug tox vs. OIs, Mortality Days of anti-tb Rx prior to ART Incidence of IRIS 0-30 100% 31-60 33% 61-90 14% 91-120 7% >120 0% Early ART reduces morbidity and mortality NIH: CD4 count <500 cells/mm3: within 2 4 weeks of TB Rx CD4 count >500 cells/mm3: within 8 weeks of TB Rx WHO: ASAP (within 8 weeks) Can defer for 2 months with high IRIS mortality rate, e.g. CNS AIDS 2007 Jan 30; 21(3):335-341. Aidsinfo.nih.gov 2011 12

Management of IRIS Rule out other causes Continue ART and anti-tb Rx Treat symptomatically NSAIDS Corticosteroids Recent report: TNF-alpha inhibitors Summary Smear, PPD, CXR, culture: can be negative Tissue > Fluid for culture (e.g.pleura) Never treat with one drug adding one drug to a failing regimen starting with INH/RIF Treating LTBI without ruling out TB disease IRIS can mimic Rx failure or resistance THANK YOU! 13